AMPK signaling pathway, a fuel sensor and regulator, promotes ATP-producing and inhibits ATP-consuming pathways in various tissues. AMPK is a heterotrimer composed of alpha-catalytic and beta and gamma-regulatory subunits. Humans and rodents have two alpha and beta and three gamma isoforms; some genes are subject to alternative splicing increasing the range of possible heterotrimer combinations. Cellular stresses that inhibit ATP production or increase its consumption change the AMP:ATP ratio and activate the pathway. AMPK activation by AMP is not completely understood; the current model states that binding of AMP to the gamma subunit leads to conformational changes that allosterically activate AMPK and render phosphorylated-Thr172 unavailable for inhibitory dephosphorylation. ATP antagonizes the effect of AMP; both AMP and ATP bind in a mutually exclusive manner to the Bateman (CBS) domains of the gamma subunit. The upstream kinase, known as Lkb1, is a complex of one catalytic and two regulatory subunits; Lkb1 is believed to be âconstitutively activeâ. In certain cell types, Thr172 can be phosphorylated by calmodulin-dependent protein kinase kinases (CAmKK), in turn activated by calcium. A well known role of AMPK is in the regulation of lipid metabolism; it stimulates fatty acids oxidation and inhibits their synthesis. Phosphorylation by AMPK inhibits acetyl-CoA carboxylase (ACC) and results in reduced levels of malonyl-CoA product. Malonyl CoA is a substrate in the de novo synthesis of fatty acids and fatty acids elongation. Importantly, it is also an inhibitor of the carnitine palmitoyl transferase I, required for the transfer of primed cytosolic fatty acids into the mitochondrion where they can undergo degradative beta-oxidation. AMPK inhibits mTOR signaling pathway by activating Tsc2 and downstream of Tsc2 by inhibiting Raptor component of mTOR complex 1 [note that this effect is opposite to Tsc2 phosphorylation and inactivation by PI3K-Akt signaling downstream of insulin]. AMPK is also involved in promoting glucose uptake and utilization and integrates adipokynes and hormonal signals in both the hypothalamus and the periphery with potential impact on energy expenditure and uptake by molecular mechanisms that remain to be established. Due to its roles in fuel regulation, the AMPK pathway is regarded as a potential therapeutic target for diabetes type II, obesity and metabolic syndrome. As a note, drugs used in the treatment of insulin resistance and diabetes can activate AMPK.
AMP-activated protein kinase (AMPK) plays a key role as a master regulator of cellular energy homeostasis. The kinase is activated in response to stresses that deplete cellular ATP supplies such as low glucose, hypoxia, ischemia and heat shock. It exists as a heterotrimeric complex composed of a catalytic α subunit and regulatory β and γ subunits. Binding of AMP to the γ subunit allosterically activates the complex, making it a more attractive substrate for its major upstream AMPK kinase, LKB1. Several studies indicate that signaling through adiponectin, leptin and CAMKKβ may also be important in activating AMPK.
As a cellular energy sensor responding to low ATP levels, AMPK activation positively regulates signaling pathways that replenish cellular ATP supplies. For example, activation of AMPK enhances both the transcription and translocation of GLUT4, resulting in an increase in insulin-stimulated glucose uptake. In addition, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis via inhibition of ACC and activation of PFK2. AMPK negatively regulates several proteins central to ATP consuming processes such as TORC2, glycogen synthase, SREBP-1 and TSC2, resulting in the downregulation or inhibition of gluconeogenesis, glycogen, lipid and protein synthesis. Due to its role as a central regulator of both lipid and glucose metabolism, AMPK is considered to be a key therapeutic target for the treatment of obesity, type II diabetes mellitus, and cancer.
Cellular Processb5aea6b07bbee8bf9aff9ad1f7fdffa52a47a3bedbdcdea9ATP biosynthetic pathwayPW:0000035Pathway OntologyAMPK signaling pathwayPW:0000542Pathway Ontologyadenosine monophosphate-activated protein kinase (AMPK) signaling pathwayPW:0000542Pathway Ontology16105857PubMedRegulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase.Am J Physiol Endocrinol Metab2005Holmes BFSparling DPOlson ALWinder WWDohm GL12502487PubMedRegulation of glycogen synthase by glucose and glycogen: a possible role for AMP-activated protein kinase.Diabetes2003Halse RFryer LGMcCormack JGCarling DYeaman SJ16479585PubMedMore TORC for the gluconeogenic engine.Bioessays2006Cheng ASaltiel AR9472019PubMed4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway.Genes Dev1998Gingras ACKennedy SGO'Leary MASonenberg NHay N12740371PubMedAMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability.J Biol Chem2003Hong YHVaranasi USYang WLeff T18328803PubMedRole of AMP-activated protein kinase in autophagy and proteasome function.Biochem Biophys Res Commun2008Viana RAguado CEsteban IMoreno DViollet BKnecht ESanz P12392881PubMedInsulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways.J Mol Cell Cardiol2002Hue LBeauloye CMarsin ASBertrand LHorman SRider MH19245654PubMedLKB1 and AMP-activated protein kinase control of mTOR signalling and growth.Acta Physiol (Oxf)2009Shaw RJ2567185PubMedThe substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase.Biochim Biophys Acta1989Carling DHardie DG14651849PubMedTSC2 mediates cellular energy response to control cell growth and survival.Cell2003Inoki KZhu TGuan KL15661536PubMedTSC1-2 tumour suppressor and regulation of mTOR signalling: linking cell growth and proliferation?Curr Opin Genet Dev2005Findlay GMHarrington LSLamb RF11069105PubMedPhosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia.Curr Biol2000Marsin ASBertrand LRider MHDeprez JBeauloye CVincent MFVan den Berghe GCarling DHue L19596898PubMedMultiple signalling pathways redundantly control glucose transporter GLUT4 gene transcription in skeletal muscle.J Physiol2009Murgia MJensen TECusinato MGarcia MRichter EASchiaffino S16364253PubMedAMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1.Biochem Biophys Res Commun2006Lee WJKim MPark HSKim HSJeon MJOh KSKoh EHWon JCKim MSOh GTYoon MLee KUPark JY19098422PubMedUsing kinomics to delineate signaling pathways: control of CRTC2/TORC2 by the AMPK family.Cell Cycle2008Fu AScreaton RA16027121PubMedAkt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity.J Biol Chem2005Hahn-Windgassen ANogueira VChen CCSkeen JESonenberg NHay N